Wolverine Trading, LLC Alaunos Therapeutics, Inc. Transaction History

Wolverine Trading, LLC

$94.2 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 23, 2023	BUY	$0.43 - $0.65 $949 - $1,435	2,208 Added 10.27%	23,704 $12,000
Q1 2023 May 15, 2023	SELL	$0.46 - $0.81 $995 - $1,752	-2,164 Reduced 9.15%	21,496 $14,000
Q4 2022 Feb 14, 2023	SELL	$0.5 - $261.0 $12,187 - $6.36 Million	-24,375 Reduced 50.74%	23,660 $15,000
Q3 2022 Nov 14, 2022	SELL	$1.04 - $322.5 $9,384 - $2.91 Million	-9,024 Reduced 15.82%	48,035 $95,000
Q2 2022 Aug 15, 2022	BUY	$0.41 - $1.24 $16,621 - $50,270	40,541 Added 245.44%	57,059 $71,000
Q1 2022 May 16, 2022	BUY	$0.62 - $1.17 $10,241 - $19,326	16,518 New	16,518 $11,000
Q3 2021 Nov 12, 2021	SELL	$1.44 - $2.73 $24,219 - $45,915	-16,819 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$2.63 - $3.67 $8,597 - $11,997	3,269 Added 24.13%	16,819 $45,000
Q1 2021 May 14, 2021	SELL	$2.82 - $5.6 $60,706 - $120,551	-21,527 Reduced 61.37%	13,550 $46,000
Q4 2020 Feb 12, 2021	BUY	$2.09 - $3.09 $46,197 - $68,301	22,104 Added 170.38%	35,077 $93,000
Q2 2020 Aug 13, 2020	SELL	$2.2 - $3.71 $7,288 - $12,291	-3,313 Reduced 20.34%	12,973 $42,000
Q1 2020 May 11, 2020	SELL	$1.9 - $4.98 $112,521 - $294,925	-59,222 Reduced 78.43%	16,286 $42,000
Q4 2019 Feb 12, 2020	BUY	$3.95 - $5.35 $71,344 - $96,631	18,062 Added 31.44%	75,508 $362,000
Q3 2019 Nov 14, 2019	SELL	$4.13 - $6.94 $157,096 - $263,983	-38,038 Reduced 39.84%	57,446 $242,000
Q2 2019 Aug 20, 2019	BUY	$3.98 - $6.2 $90,453 - $140,907	22,727 Added 31.24%	95,484 $557,000
Q1 2019 May 15, 2019	SELL	$2.0 - $4.4 $33,444 - $73,576	-16,722 Reduced 18.69%	72,757 $280,000
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $144,061 - $323,913	89,479 New	89,479 $149,000
Q3 2018 Nov 14, 2018	SELL	$2.26 - $3.27 $62,201 - $90,000	-27,523 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$3.46 - $5.14 $69,504 - $103,252	-20,088 Reduced 42.19%	27,523 $108,000
Q4 2017 Feb 14, 2018	BUY	$4.0 - $6.54 $127,976 - $209,240	31,994 Added 204.87%	47,611 $197,000
Q3 2017 Nov 15, 2017	BUY	$4.99 - $6.57 $77,928 - $102,603	15,617	15,617 $96,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account